Niche Market First in Monmouth County and Jersey Shore to adopt FDA-approved Transcranial Magnetic Stimulation (TMS) for depression offers a differentiated position. Potential upsell: expand to broader patient base seeking non-pharmacologic depression treatments and elderly-focused TMS programs.

Elderly Focus Recent launch targeting elderly patients signals a prime entry for partnerships with senior care facilities, geriatric clinics, and home health networks to drive referrals and managed care programs.

Strategic Partnerships Partnership with NeuroStar (neurostimulation technology) can be leveraged to co-market and expand reimbursement strategies. Opportunities to resell or co-create patient care bundles with partner devices and training.

Local Presence Small team with geographic concentration in New Jersey presents a growth-by-referral path. Consider outreach to local primary care networks, psychiatrists, and hospital systems in the Jersey Shore corridor.

Growth Potential Revenue in the mid-single digits to low double digits; scalable via broader marketing, payer negotiations, and expanded clinic hours. Potential to benchmark against peers to optimize cost structure and service line expansions.